Dopamine D4 receptor counteracts morphine-induced changes in μ opioid receptor signaling in the striosomes of the rat caudate putamen

International Journal of Molecular Sciences

Volumn 15, Issue 1, 2014, Pages 1481-1498

  Suárez Boomgaard, Diana ^a   Gago, Belén ^b   Valderrama Carvajal, Alejandra ^a   Roales Buján, Ruth ^a   Van Craenenbroeck, Kathleen ^c   Duchou, Jolien ^c   Borroto Escuela, Dasiel O ^d   Medina Luque, José ^a   de la Calle, Adelaida ^a   Fuxe, Kjell ^d   Rivera, Alicia ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^c GHENT UNIVERSITY   (Belgium)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Opioid receptor; Addiction; Caudate putamen; Dopamine D4 receptor; G proteins; Morphine; PD168,077; Striosomes

Indexed keywords

3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL] METHYL] 1H PYRROLO [2, 3 B] PYRIDINE; DOPAMINE 4 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MORPHINE; MU OPIATE RECEPTOR; N [4 (2 CYANOPHENYL) 1 PIPERAZINYLMETHYL] 3 METHYLBENZAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CAUDATE NUCLEUS; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PUTAMEN; RAT; UPREGULATION; WESTERN BLOTTING;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; DOPAMINE AGONISTS; DYNORPHINS; ENKEPHALINS; MALE; MORPHINE; PUTAMEN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D4; RECEPTORS, OPIOID, MU; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84892883190     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15011481     Document Type: Article

References (49)

1. Bloodworth, D. Issues in opioid management. Am. J. Phys. Med. Rehabil. 2005, 84, S42-S55.
2. Hyman, S.E.; Malenka, R.C.; Nestler, E.J. Neural mechanisms of addiction: The role of reward-related learning and memory. Annu. Rev. Neurosci. 2006, 29, 565-598.
3. Stewart, J.; Badiani, A. Tolerance and sensitization to the behavioral effects of drugs. Behav. Pharmacol. 1993, 4, 289-312.
4. Bodnar, R.J.; Klein, G.E. Endogenous opiates and behaviour: 2005. Peptides 2006, 27, 3391-3478.
5. Gavériaux-Ruff, C.; Kieffer, B.L. Opioid receptor genes inactivated in mice: The highlights. Neuropeptides 2002, 36, 62-71.
6. Lutz, P.E.; Kieffer, B.L. The multiple facets of opioid receptor function: Implications for addiction. Curr. Opin. Neurobiol. 2013, 23, 473-479.
7. Matthes, H.W.; Maldonado, R.; Simonin, F.; Valverde, O.; Slowe, S.; Kitchen, I.; Befort, K.; Dierich, A.; le Meur, M.; Dollé, P. et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene. Nature 1996, 383, 819-823.
8. Margolis, E.B.; Hjelmstad, G.O.; Bonci, A.; Fields, H.L. Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons. J. Neurosci. 2003, 23, 9981-9986.
9. Wee, S.; Koob, G.F. The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse. Psychopharmacology 2010, 210, 121-135.
10. Le Merrer, J.; Plaza-Zabala, A.; del Boca, C.; Matifas, A.; Maldonado, R.; Kieffer, B.L. Deletion of the δ opioid receptor gene impairs place conditioning but preserves morphine reinforcement. Biol. Psychiatry 2011, 69, 700-703.
11. Borroto-Escuela, D.O.; Romero-Fernandez, W.; Rivera, A.; van Craenenbroeck, K.; Tarakanov, A.O.; Agnati, L.F.; Fuxe, K. On the G-protein-coupled receptor heteromers and their allosteric receptor-receptor interactions in the central nervous system: Focus on their role in pain modulation. Evid. Based Complement. Alternat. Med. 2013, 2013, 563716.
12. Costantino, C.M.; Gomes, I.; Stockton, S.D.; Lim, M.P.; Devi, L.A. Opioid receptor heteromers in analgesia. Expert. Rev. Mol. Med. 2012, 14, e9.
13. Kabli, N.; Martin, N.; Fan, T.; Nguyen, T.; Hasbi, A.; Balboni, G.; O'Dowd, B.F.; George, S.R. Agonists at the δ-opioid receptor modify the binding of μ-receptor agonists to the μ-δ receptor hetero-oligomer. Br. J. Pharmacol. 2010, 161, 1122-1136.
14. Gerrits, M.A.; Lesscher, H.B.; van Ree, J.M. Drug dependence and the endogenous opioid system. Eur. Neuropsychopharmacol. 2003, 13, 424-434.
15. Badiani, A.; Belin, D.; Epstein, D.; Calu, D.; Shaham, Y. Opiate versus psychostimulant addiction: The differences do matter. Nat. Rev. Neurosci. 2011, 12, 685-700.
16. Di Chiara, G.; Imperato, A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA 1988, 85, 5274-5278.
17. Johnson, S.W.; North, R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 1992, 12, 483-488.
18. Margolis, E.B.; Toy, B.; Himmels, P.; Morales, M.; Fields, H.L. Identification of rat ventral tegmental area GABAergic neurons. PLoS One 2012, 7, e42365.
19. Arvidsson, U.; Riedl, M.; Chakrabarti, S.; Lee, J.H.; Nakano, A.H.; Dado, R.J.; Loh, H.H.; Law, P.Y.; Wessendorf, M.W.; Elde, R. Distribution and targeting of a μ-opioid receptor (MOR1) in brain and spinal cord. J. Neurosci. 1995, 15, 3328-3341.
20. Fujiyama, F.; Sohn, J.; Nakano, T.; Furuta, T.; Nakamura, K.C.; Matsuda, W.; Kaneko, T. Exclusive and common targets of neostriatofugal projections of rat striosome neurons: A single neuron-tracing study using a viral vector. Eur. J. Neurosci. 2011, 33, 668-677.
21. Watabe-Uchida, M.; Zhu, L.; Ogawa, S.K.; Vamanrao, A.; Uchida, N. Whole-brain mapping of direct inputs to midbrain dopamine neurons. Neuron 2012, 74, 858-873.
22. Kieffer, B.L.; Evans, C.J. Opioid tolerance in search of the Holy Grail. Cell 2002, 108, 587-590.
23. Brady, L.S.; Herkenham, M.; Long, J.B.; Rothman, R.B. Chronic morphine increases μ-opiate receptor binding in rat brain: A quantitative autoradiographic study. Brain Res. 1989, 477, 382-386.
24. Goodman, C.B.; Emilien, B.; Becketts, K.; Cadet, J.L.; Rothman, R.B. Downregulation of mu-opioid binding sites following chronic administration of neuropeptide FF (NPFF) and morphine. Peptides 1996, 17, 389-397.
25. Viganò, D.; Rubino, T.; di Chiara, G.; Ascari, I.; Massi, P.; Parolaro, D. Mu opioid receptor signaling in morphine sensitization. Neuroscience 2003, 117, 921-929.
26. Gago, B.; Fuxe, K.; Agnati, L.; Penafiel, A.; de la Calle, A.; Rivera, A. Dopamine D(4) receptor activation decreases the expression of μ-opioid receptors in the rat striatum. J. Comp. Neurol. 2007, 502, 358-366.
27. Rivera, A.; Cuellar, B.; Giron, F.J.; Grandy, D.K.; de la Calle, A.; Moratalla, R. Dopamine D4 receptors are heterogeneously distributed in the striosomes/matrix compartments of the striatum. J. Neurochem. 2002, 80, 219-229.
28. Gago, B.; Suárez-Boomgaard, D.; Fuxe, K.; Brené, S.; Reina-Sánchez, M.D.; Rodríguez-Pérez, L.M.; Agnati, L.F.; de la Calle, A.; Rivera, A. Effect of acute and continuous morphine treatment on transcription factor expression in subregions of the rat caudate putamen. Marked modulation by D4 receptor activation. Brain Res. 2011, 1407, 47-61.
29. Gago, B.; Fuxe, K.; Brené, S.; Díaz-Cabiale, Z.; Reina-Sánchez, M.D.; Suárez-Boomgaard, D.; Roales-Buján, R.; Valderrama-Carvajal, A.; de la Calle, A.; Rivera, A. Early modulation by the dopamine D4 receptor of morphine-induced changes in the opioid peptide systems in the rat caudate putamen. J. Neurosci. Res. 2013, 91, 1533-1540.
30. Fuxe, K.; Marcellino, D.; Rivera, A.; Diaz-Cabiale, Z.; Filip, M.; Gago, B.; Roberts, D.C.; Langel, U.; Genedani, S.; Ferraro, L.; de la Calle, A.; et al. Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology. Brain Res. Rev. 2008, 58, 415-452.
31. Winzer-Serhan, U.H.; Chen, Y.; Leslie, F.M. Expression of opioid peptides and receptors in striatum and substantia nigra during rat brain development. J. Chem. Neuroanat. 2003, 26, 17-36.
32. Tajima, K.; Fukuda, T. Region-specific diversity of striosomes in the mouse striatum revealed by the differential immunoreactivities for mu-opioid receptor, substance P, and enkephalin. Neuroscience 2013, 241, 215-228.
33. Miura, M.; Saino-Saito, S.; Masuda, M.; Kobayashi, K.; Aosaki, T. Compartment-specific modulation of GABAergic synaptic transmission by mu-opioid receptor in the mouse striatum with green fluorescent protein-expressing dopamine islands. J. Neurosci. 2007, 27, 9721-9728.
34. De Vries, T.J.; Tjon Tien Ril, G.H.; van der Laan, J.W.; Mulder, A.H.; Schoffelmeer, A.N. Chronic exposure to morphine and naltrexone induces changes in catecholaminergic neurotransmission in rat brain without altering μ-opioid receptor sensitivity. Life Sci. 1993, 52, 1685-1693.
35. Stafford, K.; Gomes, A.B.; Shen, J.; Yoburn, B.C. Mu-opioid receptor downregulation contributes to opioid tolerance in vivo. Pharmacol. Biochem. Behav. 2001, 69, 233-237.
36. Danks, J.A.; Tortella, F.C.; Long, J.B.; Bykov, V.; Jacobson, A.E.; Rice, K.C.; Holaday, J.W.; Rothman, R.B. Chronic administration of morphine and naltrexone up-regulate [3H][D-Ala2, D-leu5]enkephalin binding sites by different mechanisms. Neuropharmacology 1988, 27, 965-974.
37. Trujillo, K.A.; Kubota, K.S.; Warmoth, K.P. Continuous administration of opioids produces locomotor sensitization. Pharmacol. Biochem. Behav. 2004, 79, 661-669.
38. Narita, M.; Imai, S.; Nakamura, A.; Ozeki, A.; Asato, M.; Rahmadi, M.; Sudo, Y.; Hojo, M.; Uezono, Y.; Devi, L.A.; Kuzumaki, N.; Suzuki, T. Possible involvement of prolonging spinal μ-opioid receptor desensitization in the development of antihyperalgesic tolerance to μ-opioids under a neuropathic pain-like state. Addict. Biol. 2013, 18, 614-622.
39. Fábián, G.; Bozó, B.; Szikszay, M.; Horváth, G.; Coscia, C.J.; Szücs, M. Chronic morphine-induced changes in μ-opioid receptors and G proteins of different subcellular loci in rat brain. J. Pharmacol. Exp. Ther. 2002, 302, 774-780.
40. Juhasz, J.R.; Hasbi, A.; Rashid, A.J.; So, C.H.; George, S.R.; O'Dowd, B.F. Mu-opioid receptor heterooligomer formation with the dopamine D1 receptor as directly visualized in living cells. Eur. J. Pharmacol. 2008, 581, 235-243.
41. Léna, I.; Bradshaw, S.; Pintar, J.; Kitchen, I. Adaptive changes in the expression of central opioid receptors in mice lacking the dopamine D2 receptor gene. Neuroscience 2008, 153, 773-788.
42. Canales, J.J. Stimulant-induced adaptations in neostriatal matrix and striosome systems: Transiting from instrumental responding to habitual behavior in drug addiction. Neurobiol. Learn. Mem. 2005, 83, 93-103.
43. Crittenden, J.R.; Graybiel, A.M. Basal Ganglia disorders associated with imbalances in the striatal striosome and matrix compartments. Front. Neuroanat. 2011, 5, 59.
44. White, N.M.; Hiroi, N. Preferential localization of self-stimulation sites in striosomes/patches in the rat striatum. Proc. Natl. Acad. Sci. USA 1998, 95, 6486-6491.
45. Douglass, J.; McKinzie, A.A.; Pollock, K.M. Identification of multiple DNA elements regulating basal and protein kinase A-induced transcriptional expression of the rat prodynorphin gene. Mol. Endocrinol. 1994, 8, 333-344.
46. Zurawski, G.; Benedik, M.; Kamb, B.J.; Abrams, J.S.; Zurawski, S.M.; Lee, F.D. Activation of mouse T-helper cells induces abundant preproenkephalin mRNA synthesis. Science 1986, 232, 772-775.
47. Skieterska, K.; Duchou, J.; Lintermans, B.; Van Craenenbroeck, K. Detection of G protein-coupled receptor (GPCR) dimerization by coimmunoprecipitation. Methods Cell Biol. 2013, 117, 323-340.
48. Van Craenenbroeck, K.; Clark, S.D.; Cox, M.J.; Oak, J.N.; Liu, F.; Van Tol, H.H. Folding efficiency is rate-limiting in dopamine D4 receptor biogenesis. J. Biol. Chem. 2005, 280, 19350-19357.
49. Pfeiffer, M.; Koch, T.; Schröder, H.; Laugsch, M.; Höllt, V.; Schulz, S. Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization. J. Biol. Chem. 2002, 277, 19762-19772.